Rani Therapeutics Holdings, Inc. (RANI)
RANI Stock Price Chart
Explore Rani Therapeutics Holdings, Inc. interactive price chart. Choose custom timeframes to analyze RANI price movements and trends.
RANI Company Profile
Discover essential business fundamentals and corporate details for Rani Therapeutics Holdings, Inc. (RANI) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
30 Jul 2021
Employees
105.00
Website
https://www.ranitherapeutics.comCEO
Talat Imran
Description
Rani Therapeutics Holdings, Inc. functions as a clinical-stage biopharmaceutical enterprise focused on revolutionizing the delivery of biologic therapies through oral administration. Its flagship innovation, the RaniPill capsule, aims to supplant conventional subcutaneous or intravenous injections of biologics with a more convenient oral dosing method. The company maintains a comprehensive portfolio of investigational treatments. Among these is RT-101, an octreotide, which has progressed beyond Phase I clinical trials for the management of neuroendocrine tumors and acromegaly. Another promising candidate is RT-105, an anti-TNF-alpha antibody designed to address psoriatic arthritis. Additionally, RT-102, a parathyroid hormone for osteoporosis, is currently advancing through preclinical studies. Other therapies under development include RT-109, a human growth hormone for treating growth hormone deficiency; RT-110, a parathyroid hormone aimed at hypoparathyroidism; and RT-106, a basal insulin formulated for type 2 diabetes. Established in 2012, the company's corporate base is located in San Jose, California.
RANI Financial Timeline
Browse a chronological timeline of Rani Therapeutics Holdings, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 Aug 2026
EPS estimate is -$0.05, while revenue estimate is $925.00k.
Earnings released on 15 May 2026
EPS came in at -$0.04 surpassing the estimated -$0.06 by +33.33%, while revenue for the quarter reached $1.71m , beating expectations by +51.82%.
Earnings released on 26 Mar 2026
EPS came in at -$0.07 falling short of the estimated -$0.03 by -133.33%, while revenue for the quarter reached $1.46m , missing expectations by -70.78%.
Earnings released on 6 Nov 2025
EPS came in at -$0.12 falling short of the estimated -$0.09 by -33.33%.
Earnings released on 7 Aug 2025
EPS came in at -$0.18 surpassing the estimated -$0.19 by +5.26%.
Earnings released on 13 May 2025
EPS came in at -$0.22 matching the estimated -$0.22, while revenue for the quarter reached $172.00k .
Earnings released on 31 Mar 2025
EPS came in at -$0.27 falling short of the estimated -$0.24 by -12.50%, while revenue for the quarter reached $1.03m .
Earnings released on 14 Nov 2024
EPS came in at -$0.24 falling short of the estimated -$0.22 by -9.09%.
Earnings released on 6 Aug 2024
EPS came in at -$0.26 surpassing the estimated -$0.29 by +10.34%.
Earnings released on 6 May 2024
EPS came in at -$0.29 falling short of the estimated -$0.23 by -26.09%.
Earnings released on 20 Mar 2024
EPS came in at -$0.27 surpassing the estimated -$0.31 by +12.90%, while revenue for the quarter reached $2.75m .
Earnings released on 8 Nov 2023
EPS came in at -$0.36 surpassing the estimated -$0.47 by +23.40%.
Earnings released on 11 Aug 2023
EPS came in at -$0.37 surpassing the estimated -$0.40 by +7.50%.
Earnings released on 10 May 2023
EPS came in at -$0.33 surpassing the estimated -$0.47 by +29.79%.
Earnings released on 22 Mar 2023
EPS came in at -$0.35 falling short of the estimated -$0.26 by -34.62%.
Earnings released on 10 Nov 2022
EPS came in at -$0.33 matching the estimated -$0.33.
Earnings released on 10 Aug 2022
EPS came in at -$0.31 falling short of the estimated -$0.28 by -10.71%.
Earnings released on 11 May 2022
EPS came in at -$0.29 surpassing the estimated -$1.00 by +71.00%.
Earnings released on 29 Mar 2022
EPS came in at -$0.27 surpassing the estimated -$1.28 by +78.91%, while revenue for the quarter reached -$2.72m , missing expectations by -1.77k%.
Earnings released on 15 Nov 2021
EPS came in at -$0.16 surpassing the estimated -$0.21 by +23.81%.
Earnings released on 13 Sept 2021
EPS came in at -$0.12 surpassing the estimated -$0.18 by +33.33%, while revenue for the quarter reached $1.96m .
Earnings released on 2 Aug 2021
EPS came in at -$0.30 , while revenue for the quarter reached $756.00k .
RANI Stock Performance
Access detailed RANI performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
